Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Beneficial Ownership Report · SCHEDULE 13G/A

Optimi Health Corp.

Beneficial Ownership Report

Filed Oct 5, 2026Accepted Oct 5, 2026, 4:45 PM EDTFiling CIK 2027329Accession 0001104659-26-113723
Share

Structured filing — SCHEDULE 13G/A

primary_doc.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Subject company

Company
Optimi Health Corp.
Company CIK
0002027329
Street
269 David Brown Way
City
Princeton
State / country code
A1
Postal code
VOX 1WO

Statement details

Amendment number
1
Security class
Common Stock, with no par value
Event date
09/30/2026
Rule designation
Rule 13d-1(c)

Reporting person 1

Name
YA II PN, Ltd.
Citizenship / organization
E9
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Reporting person 2

Name
YA Global Investments II (U.S.), LP
Citizenship / organization
DE
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Reporting person 3

Name
Yorkville Advisors Global, LP
Citizenship / organization
DE
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Reporting person 4

Name
Yorkville Advisors Global II, LLC
Citizenship / organization
DE
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Reporting person 5

Name
YAII GP, LP
Citizenship / organization
DE
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Reporting person 6

Name
YAII GP II, LLC
Citizenship / organization
DE
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Reporting person 7

Name
Mark Angelo
Citizenship / organization
NJ
Reporting person type
OO
Group designation
a
Aggregate amount owned
173,000.00
Percent of class
3.0
Sole voting power
0.00
Shared voting power
173,000.00
Sole dispositive power
0.00
Shared dispositive power
173,000.00
Aggregate excludes certain shares
N

Item 1

Issuer

Optimi Health Corp.

Principal executive office address

269 David Brown Way, Princeton, A1 VOX 1WO

Item 2

Citizenship

Cayman Islands

Filing person

YA II PN, Ltd.

Principal business or residence address

1012 Springfield Ave., Mountainside, NJ 07092

Item 3

Not applicable indication

N

Type of filing person

OO

Item 4

Percent of class

3.0

Amount beneficially owned

173,000

Sole voting power

0

Shared voting power

173,000

Sole dispositive power

0

Shared dispositive power

173,000

Item 5

Not applicable indication

N

Ownership of 5% or less

Y

Item 6

Not applicable indication

Y

Item 7

Not applicable indication

Y

Item 8

Not applicable indication

N

Group members

YA II is beneficially owned by YA Global Investments II (U.S.), LP (the "YA Feeder"). Yorkville Advisors Global, LP (the "YA Advisor") is the investment manager to YA II. Yorkville Advisors Global II, LLC (the "YA Advisor GP") is the general partner to the YA Advisor. YAII GP, LP (the "YA GP") is the general partner to the YA Feeder. YAII GP II, LLC (the "Yorkville GP") is the general partner to the YA GP. Mark Angelo makes the investment decisions on behalf of YA II. Accordingly, each of YA II, YA Feeder, the YA Advisor, the YA Advisor GP, the YA GP, the Yorkville GP and Mark Angelo may be deemed affiliates and therefore may be deemed to beneficially own the same number of Class A Shares. YAII GP, LP is the general partner of SC-Sigma Global Partners, LP ("SC-Sigma"), which is an investor in YA II. YAII GP II, LLC is the general partner of YAII GP, LP. The YA Advisor is the investment manager to SC-Sigma. Accordingly, SC-Sigma, the YA GP, the Yorkville GP, the YA Advisor, and Mark Angelo may be deemed affiliates and therefore may be deemed to beneficially own the same number of shares of Class A Shares. For purposes of this filing, each of the reporting persons is deemed an affiliate of each other reporting person.

Item 9

Not applicable indication

Y

Item 10

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Signature 1

Reporting person
YA II PN, Ltd.
Signed
/s/ David Gonzalez
Title
David Gonzalez, General Counsel
Date
10/05/2026

Signature 2

Reporting person
YA Global Investments II (U.S.), LP
Signed
/s/ David Gonzalez
Title
David Gonzalez, General Counsel
Date
10/05/2026

Signature 3

Reporting person
Yorkville Advisors Global, LP
Signed
/s/ David Gonzalez
Title
David Gonzalez, General Counsel
Date
10/05/2026

Signature 4

Reporting person
Yorkville Advisors Global II, LLC
Signed
/s/ David Gonzalez
Title
David Gonzalez, General Counsel
Date
10/05/2026

Signature 5

Reporting person
YAII GP, LP
Signed
/s/ David Gonzalez
Title
David Gonzalez, General Counsel
Date
10/05/2026

Signature 6

Reporting person
YAII GP II, LLC
Signed
/s/ David Gonzalez
Title
David Gonzalez, General Counsel
Date
10/05/2026

Signature 7

Reporting person
Mark Angelo
Signed
/s/ Mark Angelo
Title
Mark Angelo
Date
10/05/2026

Company context

We are a Canadian Good Manufacturing Practices (“GMP”) compliant, pharmaceutical drug manufacturer licensed by Health Canada for the handling of controlled substances and GMP production. We specialize in controlled substances with our products being 3,4-Methylenedioxymethamphetamine hydrochloride (“MDMA”) and psilocybin derived from botanical sources. With a vertically integrated approach, we own two approximately 10,000-square-foot production facilities on leased land in Princeton, British Columbia and operate under a Drug Establishment Licence (“DEL”) awarded by Health Canada. Our DEL certifies that our facilities and quality management systems comply with GMP for the formulation of designated drug products and the manufacture of certain active pharmaceutical ingredients (“API”) from plant sources. Additionally, we hold a Dealer’s Licence (“DL”) under Canada’s Narcotic Control Regulations, allowing us to possess, produce, assemble, sell, and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada. The DL allows us to possess up to 20kg of psilocybin and 200g of psilocin (equivalent to approximately 2,000kg of dried full-body psilocybin-containing mushrooms) and 2kg of MDMA. We also hold a Precursor Licence under Canada’s Precursor Regulations allowing us to import 3,4-Methylenedioxyphenyl-2-Propanone if used in the synthesis of MDMA.

Current securities

Historical securities (2)

Recent company filings

  1. 6-K filingOct 7, 2026
  2. 6-K filingSep 29, 2026
  3. 6-K filingSep 23, 2026
  4. 6-K filingSep 22, 2026
  5. 6-K filingSep 16, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.